Moreover, a recent large retrospective cohort study including 41753 participants with insulin-treated diabetes, of whom 36 080 with type 2 diabetes, showed that among adults who started rtCGM, those with type 2 diabetes had greater improvements in HbA1c than patients with type 1 diabetes associated with reductions in emergency department visits and hospitalizations for hypoglycemia [29]. The gene discussed is INS; the disease is type 2 diabetes mellitus.